PharmaJet and Mundipharma partner to expand access to needle-free technology in emerging markets

SINGAPORE — July 25, 2018 — PharmaJet® the maker of innovative, needle-free injection technology, and Mundipharma, today announced an exclusive partnership for the multinational healthcare organization to market and distribute PharmaJet’s Tropis® and Stratis® needle-free devices across more than 120 markets worldwide. Tropis® (ID) and Stratis® (IM/SC) devices are both optimized for vaccine immunizations.